A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable ...
A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable ...
In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of ...
A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...
Lunai Bioworks (LNAI) has announced a major scientific breakthrough: its next-generation immune cell therapy led to complete regression of both ...
LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, ...
Edited by Moses Chao, New York University Langone Medical Center, New York, NY; received May 13, 2025; accepted August 7, 2025 ...
GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to ...